These fusion proteins have a broader affinity for VEGF molecules and have shown significant therapeutic effects on the treatment of AMD.3,44 In this study, we used VEGFR-Fc fusion protein as the target molecule and aimed to identify peptide ligands that can bind to VEGFR-1 and VEGFR-2. Here, KDR is linked to age-related macular degeneration.